Quantcast
Last updated on April 19, 2014 at 1:20 EDT
Parkinsons Patients May Retain Independence Using Google

Parkinson's Patients May Retain Independence Using Google Glass

Enid Burns for redOrbit.com - Your Universe Online Researchers as Newcastle University in the UK are studying how Google Glass can be used as an assistive aid to help people with Parkinson's disease -- the wearable technology might help...

Latest Parkinson's disease Stories

2014-04-18 12:22:35

Join us at the largest grassroots event in the U.S. to raise awareness and funds for Parkinson's research KINGSTON, N.J., April 18, 2014 /PRNewswire-USNewswire/ -- The Parkinson Alliance announced today that the 20(th) Parkinson's Unity Walk will take place on Saturday, April 26, 2014, in New York City's Central Park. The Parkinson's Unity Walk is the largest grassroots event for Parkinson's disease; uniting thousands of supporters from across the country in a common goal; to raise...

2014-04-18 09:59:31

Attack by own immune system may kill neurons in Parkinson's disease The cause of neuronal death in Parkinson's disease is still unknown, but a new study proposes that neurons may be mistaken for foreign invaders and killed by the person's own immune system, similar to the way autoimmune diseases like type I diabetes, celiac disease, and multiple sclerosis attack the body's cells. The study was published April 16, 2014, in Nature Communications. "This is a new, and likely controversial,...

2014-04-16 16:13:04

New screening technique opens the door to unlimited opportunities, both in terms of chemistry and biology research Researchers at Griffith University's Eskitis Institute have developed a new technique for discovering natural compounds which could form the basis of novel therapeutic drugs. The corresponding author, Professor Ronald Quinn AM said testing the new process on a marine sponge had delivered not only confirmation that the system is effective, but also a potential lead in the...

2014-04-16 08:28:05

KANSAS CITY, Mo., April 16, 2014 /PRNewswire/ -- When Jack McDonald elected to have Deep Brain Stimulation (DBS) surgery after more than a decade of watching his tremors and other symptoms get progressively worse, he saw it as a teachable moment for his grandchildren. Their reactions to his brain surgery experience were the inspiration for Poppo's Electric Brain, an educational new children's book that makes Parkinson's disease and DBS more understandable for young people. More...

2014-04-14 12:32:55

Researchers recruiting patients with mild to moderate Alzheimer's disease to participate in six week study SUN CITY, Ariz., April 14, 2014 /PRNewswire/ -- Banner Sun Health Research Institute is proud to announce it is one of just five facilities in the United States to launch a new clinical trial for patients with mild to moderate Alzheimer's disease (AD). This study, titled "Effect of NeuroAD(TM), Combined TMS Stimulation and Cognitive Training, on the cognitive function of mild to...

2014-04-11 08:24:27

LA JOLLA, Calif., April 11, 2014 /PRNewswire-iReach/ -- On March 4, 2014, ICB International, Inc., ("ICBI"), announced the development of a tracer for imaging alpha-synuclein (a-Syn) in Parkinson's-like mice at the Keystone Symposium for Parkinson disease (PD) in Keystone,Colorado. Speaking at the symposium, Dr. Anna Cartier, Associate Director of ICBI, presented scientific data and showed images for the first successful live visualization of a-Syn in the brains of mice with and...

2014-04-11 08:24:24

HAYWARD, Calif., April 11, 2014 /PRNewswire/ -- Impax Pharmaceuticals, a division of Impax Laboratories, Inc. (NASDAQ: IPXL), announced today the resubmission of Impax's New Drug Application (NDA) for RYTARY (IPX066) to the U.S. Food and Drug Administration (FDA). IPX066 is a patented extended- release capsule formulation of carbidopa and levodopa, an investigational drug for the symptomatic treatment of Parkinson's disease (PD). After discussions with the FDA, the Company has...

2014-04-10 16:22:44

PHOENIX, April 10, 2014 /PRNewswire/ -- On the eve of the 20(th) anniversary of Celebrity Fight Night, the Muhammad Ali Parkinson Center is unveiling an extensive expansion that doctors say will help thousands more patients receive care. http://photos.prnewswire.com/prnvar/20140410/LA03005 The Center is the primary beneficiary of Celebrity Fight Night, an annual fundraising gala that will be held this year in Phoenix on April 12. Celebrity Fight Night attracts generous...

2014-04-10 08:28:50

DUODOPA improves quality of life for those with advanced stages of disease MONTREAL, April 10, 2014 /CNW/ - AbbVie today announced that a new treatment called DUODOPA(® )(levodopa/carbidopa intestinal gel) is now available to Canadians with advanced Parkinson's disease. Currently, more than 100,000 Canadians live with Parkinson's - a progressive, incurable neurological disorder that can significantly affect the quality of life of patients, their families and caregivers. DUODOPA is approved...